Germany · Delayed Price · Currency is EUR PiùMedical Statistics
Total Valuation
PiùMedical has a market cap or net worth of EUR 41.33 million. The enterprise value is 51.09 million.
| Market Cap | 41.33M |
| Enterprise Value | 51.09M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 6.35M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 2.85M |
Valuation Ratios
The trailing PE ratio is 145.03 and the forward PE ratio is 37.57.
| PE Ratio | 145.03 |
| Forward PE | 37.57 |
| PS Ratio | 1.58 |
| PB Ratio | 1.77 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 179.25 |
| EV / Sales | 1.96 |
| EV / EBITDA | 31.59 |
| EV / EBIT | 103.21 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.35, with a Debt / Equity ratio of 0.41.
| Current Ratio | 0.35 |
| Quick Ratio | 0.11 |
| Debt / Equity | 0.41 |
| Debt / EBITDA | 5.91 |
| Debt / FCF | n/a |
| Interest Coverage | 1.01 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 1.70% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, PiùMedical has paid 419,000 in taxes.
| Income Tax | 419,000 |
| Effective Tax Rate | 59.52% |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 52.16 |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, PiùMedical had revenue of EUR 26.11 million and earned 285,000 in profits. Earnings per share was 0.06.
| Revenue | 26.11M |
| Gross Profit | 6.14M |
| Operating Income | 495,000 |
| Pretax Income | 704,000 |
| Net Income | 285,000 |
| EBITDA | 1.62M |
| EBIT | 495,000 |
| Earnings Per Share (EPS) | 0.06 |
Balance Sheet
The company has 50,000 in cash and 9.55 million in debt, with a net cash position of -9.50 million.
| Cash & Cash Equivalents | 50,000 |
| Total Debt | 9.55M |
| Net Cash | -9.50M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 23.31M |
| Book Value Per Share | 4.53 |
| Working Capital | -6.21M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 23.51%, with operating and profit margins of 1.90% and 1.09%.
| Gross Margin | 23.51% |
| Operating Margin | 1.90% |
| Pretax Margin | 2.70% |
| Profit Margin | 1.09% |
| EBITDA Margin | 6.19% |
| EBIT Margin | 1.90% |
| FCF Margin | n/a |
Dividends & Yields
PiùMedical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 0.69% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
PiùMedical has an Altman Z-Score of 0.57 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.57 |
| Piotroski F-Score | 1 |